[Treatment for chronic hepatitis C with thrombocytopenia]

Norihiro Furusyo, Eiichi Ogawa, Masayuki Murata, Jun Hayashi

研究成果: ジャーナルへの寄稿総説査読

抄録

Thrombocytopenia in patients with chronic hepatitis C represents an obstacle for the initiation of antiviral treatment. Antiviral treatment with pegylated interferon α and ribavirin has contributed to a significant increase in the rate of sustained virological response. However, patients with thrombocytopenia is ineligible for antiviral treatment or, if able to start treatment, may require a dose reduction or even discontinuation due to the haematological adverse effects. We here review the efficacy and safety of antiviral treatment after splenectomy and partial splenic embolization, and the potential effect of platelet count increase by interferon β.

本文言語英語
ページ(範囲)299-303
ページ数5
ジャーナルNihon rinsho. Japanese journal of clinical medicine
73
2
出版ステータス出版済み - 2月 1 2015

!!!All Science Journal Classification (ASJC) codes

  • 医学(全般)

フィンガープリント

「[Treatment for chronic hepatitis C with thrombocytopenia]」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル